PIPAC Pharmacologic and Clinical Data
Publication date
2024-11
Authors
Cortés-Guiral, Delia
Kranenburg, Onno
Sgarbura, Olivia
Van Der Speeten, Kurt
Taibi, Albdelkader
Hübner, Martin
Yacoov, Almog Ben
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of systemic therapies to induce response in peritoneal malignancies. Promising results for patients with mesothelioma peritonei and peritoneal metastasis from gastric, ovarian, colorectal, pancreatic, and hepatobiliary tumors origin are changing the landscape for patients otherwise just facing palliative treatment. Ongoing trials will shed more light on the actual benefits of PIPAC.
Keywords
clinical results, peritoneal metastasis, pharmacology, PIPAC, Taverne, Surgery, Oncology
Citation
Cortés-Guiral, D, Kranenburg, O, Sgarbura, O, Van Der Speeten, K, Taibi, A, Hübner, M & Yacoov, A B 2024, 'PIPAC Pharmacologic and Clinical Data', Journal of Surgical Oncology, vol. 130, no. 6, pp. 1337-1348. https://doi.org/10.1002/jso.27900